Ashwagandha Benefits: Pharmacist's Research Review

Ashwagandha has strong RCT evidence for cortisol reduction at 600 mg/day of KSM-66 root extract (Chandrasekhar et al., 2012, Indian J Psychol Med; Salve et al., 2019, Cureus), moderate evidence for sleep quality at the same dose (Langade et al., 2019), and moderate evidence for testosterone elevation in men, mainly with Shoden-form extract at 240 mg (Lopresti et al., 2019, Am J Mens Health). The strength and muscle data is real but smaller than the marketing suggests (Wankhede 2015 showed a roughly 4 kg vs 2 kg lean mass gain difference). KSM-66 is the form with the deepest RCT base; Sensoril is the second extract worth knowing. Liver injury case reports surfaced in 2020-2024 and the NIH LiverTox database now lists ashwagandha as a possible cause of drug-induced liver injury, which the supplement industry tends to downplay. Below is the pharmacist version of which benefits hold up, which forms work, drug interactions that matter, and Canadian and halal brand picks.

Why trust this review

I am Kazi Habib, B.Pharm, MBA, PMP, with 10+ years across pharmaceutical sciences and life-sciences marketing, and I run FitFixLife and PharmoniQ. The per-claim evidence rankings, form picks, and drug interaction list below come from peer-reviewed RCTs (verified on PubMed), the NIH LiverTox database, Health Canada NPN listings, and my pharmacist training in differentiating well-evidenced from marketing-evidenced supplement claims.

What ashwagandha actually is (and why the form matters)

Ashwagandha (Withania somnifera) is a plant in the nightshade family used in Ayurvedic medicine for centuries. The active compounds are a family of steroidal lactones called withanolides, plus a smaller set of withaferin A constituents. The total withanolide percentage on the label is the closest thing to a potency metric, but it does not capture the differences between extracts.

KSM-66. Developed by Ixoreal Biomed in Hyderabad, India. Standardized to at least 5% withanolides by HPLC. Root-only extract (no leaves), water-and-milk based extraction without alcohol. This is the extract with the deepest clinical trial base.

Sensoril. Developed by Natreon. Standardized to at least 10% withanolides by HPLC. Uses both root and leaf. Has its own RCT base, including studies on cardiometabolic markers and stress.

Shoden. Developed by Arjuna Natural. Standardized to higher withanolide concentration (around 35%); lower daily dose (120-240 mg). Used in the Lopresti 2019 testosterone trial.

Generic / non-branded ashwagandha extract. Variable potency, variable extraction quality, no specific RCT base. Cheaper per gram but should be assumed underpowered until you see a Certificate of Analysis that confirms withanolide content.

Halal note on ashwagandha extraction. KSM-66's water-and-milk extraction is alcohol-free, which is the halal-friendly default for the extract itself. Some other extracts use ethanol carriers in the extraction process, which is a fiqh question.

1. Stress and cortisol reduction: strong evidence

Chandrasekhar 2012. Published in Indian Journal of Psychological Medicine (PMID 23439798). 64 adults with chronic stress randomized to 300 mg twice daily of full-spectrum ashwagandha root extract or placebo for 60 days. Stress scale scores (PSS, GHQ, DASS) dropped significantly in the ashwagandha group (P < 0.0001 across measures). Serum cortisol decreased significantly (P = 0.0006).

Salve 2019. Published in Cureus (PMID 32021735). 60 healthy adults randomized to 125 mg twice daily, 300 mg twice daily, or placebo for 8 weeks. Both ashwagandha doses produced significant reductions in perceived stress and serum cortisol vs placebo, with the 600 mg/day arm showing the larger effect.

Pharmacist note on cortisol claims. The cortisol drops in these trials are real and statistically robust, but the clinical meaning depends on whether you actually had elevated cortisol to begin with. Adults with chronically high cortisol often feel calmer and sleep better when cortisol drops. Adults with normal baseline cortisol may not notice much subjective change.

2. Sleep quality: moderate evidence

Langade 2019. Published in Cureus (PMID 31728244). 80 adults randomized to 300 mg twice daily of KSM-66 or placebo for 10 weeks. Sleep onset latency was significantly shorter in the ashwagandha group (P = 0.019); sleep efficiency improved from 75.6% to 83.5%; sleep quality scores significantly improved (P = 0.002).

Comparison to magnesium for sleep. Ashwagandha and magnesium glycinate stack well; the mechanisms are different (HPA axis modulation vs NMDA/GABA modulation), and good responders often see additive benefit.

3. Testosterone in men: moderate evidence, dose-dependent

Lopresti 2019. Published in American Journal of Men's Health (PMID 30854916). 57 overweight men aged 40-70 with mild fatigue, 16-week crossover, 240 mg/day Shoden ashwagandha or placebo. Testosterone increased 14.7% more in the ashwagandha arm (P = 0.010); DHEA-S increased 18% more (P = 0.005). Cortisol and estradiol were unchanged.

Wankhede 2015. Published in JISSN (PMID 26609282). 57 young male resistance training novices, 300 mg twice daily of ashwagandha root extract for 8 weeks. Testosterone increased 96.2 ng/dL in the ashwagandha arm vs 18.0 ng/dL in placebo. Bench press strength gains 46 kg vs 26.4 kg.

Pharmacist note. The effect sizes are real but the clinical meaning needs context. A 14.7% testosterone increase from a baseline of 400 ng/dL takes you to 460 ng/dL. That is statistically significant but not TRT-like.

4. Strength and muscle gain: moderate evidence in novices

The Wankhede 2015 trial above is the headline strength-and-muscle data. The effect sizes were larger in absolute terms than typical supplement-vs-placebo strength trials. The caveats: the population was untrained men where placebo variance is high; the placebo arm's strength gains were lower than typical for novice resistance training; reproducibility in trained athletes is thinner.

For trained athletes, the expected effect is more modest: 1-3% extra strength gain over a placebo arm with similar training adherence.

5. Anxiety in healthy adults: moderate evidence

The Salve 2019 trial showed anxiety reduction in healthy adults. The 2021 Speers review in Current Neuropharmacology concluded that ashwagandha "exhibited noteworthy anti-stress and anti-anxiety activity in animal and human studies" but noted variability across extract types.

Dose and form for anxiety. 300-600 mg/day KSM-66, single or split dose, for at least 8 weeks before judging effect.

6. Other claims that get marketed

• Fertility (men). Some small trials in oligospermia have shown improvements with KSM-66 at 675 mg/day for 90 days; evidence quality is lower than for stress or sleep.
• Athletic performance / VO2max. Several small trials have shown VO2max improvements with KSM-66; effect sizes are modest.
• Thyroid. A 2018 RCT showed subclinical hypothyroid patients had improvements with 600 mg KSM-66 for 8 weeks. For adults with overt hypothyroidism on levothyroxine, this is actually a caution (potential dose interaction).
• Cognitive function. Mixed evidence. Some small trials show memory improvement; others find no effect.

Liver injury safety signal: what the case reports actually say

Multiple case reports published between 2020 and 2024 describe hepatocellular and cholestatic liver injury in adults taking ashwagandha at various doses, with onset typically 2-12 weeks after starting and resolution typically within 1-5 months after stopping. The NIH LiverTox database currently lists ashwagandha as a "probable cause of clinically apparent acute liver injury" in rare cases.

What this means in practice.

• The absolute risk is low (probably less than 1 in 10,000 users).
• The risk is real enough that the NIH LiverTox database has been updated to flag it.
• The pattern is idiosyncratic, not dose-dependent in a clean curve.

Practical implications.

• Do not start ashwagandha if you have active liver disease, are on hepatotoxic medication, or have a history of drug-induced liver injury.
• If you start ashwagandha and develop jaundice, dark urine, pale stools, right-upper-quadrant pain, severe fatigue, or unexplained nausea, stop immediately and see a physician.
• For long-term users (more than 3-6 months continuous), consider baseline and 6-month follow-up liver function tests as a low-cost safety screen.

Drug interactions worth knowing

• Thyroid medications (levothyroxine, methimazole). Ashwagandha can modulate thyroid hormone levels; the 2018 subclinical hypothyroid trial showed it raises T3 and T4 and lowers TSH at 600 mg/day. Anyone on thyroid medication should discuss with their prescriber.
• Immunosuppressants (cyclosporine, tacrolimus, mycophenolate, biologics). Ashwagandha has immunomodulatory effects. Adults on these medications should avoid ashwagandha unless specifically cleared.
• Sedatives and CNS depressants (benzodiazepines, Z-drugs, alcohol). Combined use can amplify drowsiness.
• Anti-diabetic medications. Ashwagandha may modestly lower fasting glucose; monitor glucose more frequently in the first 4-6 weeks.
• Antihypertensives. Ashwagandha has shown modest BP-lowering effects in some trials.
• Hepatotoxic medications. The combination is to be avoided.
• Pregnancy and breastfeeding. Ashwagandha is contraindicated; modern safety data in pregnancy is essentially absent.

Halal certification status and Canadian market

Ashwagandha root is a plant, so the active ingredient is halal by botanical chemistry. The questions are about extraction solvents, capsule shell, and excipients.

Extraction solvents. KSM-66 uses a water-and-milk-based extraction without alcohol, which is the halal-friendly default. Brands that publish "alcohol-free extraction" or "water extraction" are the safer halal choice.

Capsule shell. Many cheap ashwagandha products use gelatin capsules without certification. HPMC vegetable capsules are the halal-friendly default. Many sleep-positioning ashwagandha softgels are gelatin (often porcine) and are not halal.

For Canadian readers, iHerb Canada is the best for KSM-66 brands (Sports Research, Jarrow, NOW); Amazon Canada carries wide selection of Canadian-made (AOR, CanPrev, New Roots) and imported brands; Shoppers Drug Mart and Rexall carry AOR and CanPrev.

Top picks

Dosing protocol summary

Side effects and who should avoid

Who should avoid completely

• Anyone with active liver disease or a history of drug-induced liver injury.
• Anyone on hepatotoxic medications (high-dose acetaminophen, isoniazid, methotrexate).
• Pregnant or breastfeeding adults.
• Adults on immunosuppressants.
• Adults with overt hyperthyroidism or on antithyroid medication.

Who should clear with prescriber first

• Adults on levothyroxine for hypothyroidism (TSH monitoring 6-8 weeks after starting).
• Adults on tight glycemic control for type 2 diabetes.
• Adults on antihypertensives where small BP shifts matter.
• Adults on chronic sedatives or benzodiazepines.

Bottom line

Ashwagandha has strong RCT support for cortisol reduction at 600 mg/day of KSM-66, moderate support for sleep quality at the same dose, and moderate support for testosterone elevation in men with KSM-66 or Shoden extracts. Strength and muscle gain effects in novice lifters are real but probably smaller in trained athletes. KSM-66 is the form with the deepest evidence base; Sensoril is the reasonable alternative for cardiometabolic use. The post-2020 liver injury case reports are a real safety signal that warrants avoiding ashwagandha in active liver disease and considering LFT monitoring for long-term users. For Canadian readers, AOR Ashwagandha (Sensoril) is the easy default; for KSM-66 specifically, Sports Research KSM-66 via iHerb Canada is the reliable pick.

If you want help fitting ashwagandha into a broader supplement stack, the FitFixLife halal supplements guide lays out which other supplements are halal-friendly defaults.